Showing 1 - 20 of 81 Results
Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health
FOA Number
Release Date
Expiration Date
Clinical Trials
Organizations
Categories
Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Notice of Special Interest (NOSI): Identification of Biomarkers of HIV Pathogenesis and Substance Use Disorder Comorbidity
FOA Number
Release Date
Expiration Date
Clinical Trials
Organizations
Categories
Prevention Strategies to End the HIV Epidemic (R01 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Categories
Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders
FOA Number
Release Date
Expiration Date
Clinical Trials
Organizations
Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19
FOA Number
Release Date
Expiration Date
Clinical Trials
Organizations
Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
FOA Number
Release Date
Expiration Date
Clinical Trials
Organizations
Categories
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
FOA Number
Release Date
Expiration Date
Clinical Trials
Organizations
Notice of Special Interest (NOSI): Promoting Research on Interoception and Its Impact on Health and Disease
FOA Number
Release Date
Expiration Date
Clinical Trials
Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
FOA Number
Release Date
Expiration Date
Clinical Trials
Organizations
Categories
Notice of Special Interest (NOSI) regarding the Use of Human Connectome Data for Secondary Analysis
FOA Number
Release Date
Expiration Date
Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Notice of Special Interest (NOSI) regarding the Use of Human Connectome Data for Secondary Analysis
FOA Number
Release Date
Expiration Date
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials